Application of neo-bioscore staging to predict the benefit of pertuzumab in HER2 positive early breast cancer

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorSanchez Escudero, L.
dc.contributor.authorMorales Pancorbo, D.
dc.contributor.authorBayo, J.
dc.contributor.authorAragon Manrique, I.
dc.contributor.authoraffiliation[Sanchez Escudero, L.] Hosp Juan Ramon Jimenez, Oncol, Huelva, Spain
dc.contributor.authoraffiliation[Morales Pancorbo, D.] Hosp Juan Ramon Jimenez, Med, Huelva, Spain
dc.contributor.authoraffiliation[Bayo, J.] Hosp Juan Ramon Jimenez, Oncol Med, Huelva, Spain
dc.contributor.authoraffiliation[Aragon Manrique, I.] Hosp Juan Ramon Jimenez, Oncol Med, Huelva, Spain
dc.date.accessioned2025-01-07T14:36:11Z
dc.date.available2025-01-07T14:36:11Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.478
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.478
dc.identifier.urihttps://hdl.handle.net/10668/26526
dc.identifier.wosID700527700198
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Juan Ramón Jiménez
dc.page.numberS442-S443
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleApplication of neo-bioscore staging to predict the benefit of pertuzumab in HER2 positive early breast cancer
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Juan Ramón Jiménez

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía